Clinical Trial Update: A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing the pharmacokinetics and pharmacodynamics of HSK39004 inhalation suspension in patients with chronic obstructive pulmo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• HSK39004

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: COPD Patients | Phase 2 | Status: ACTIVE_NOT_RECRUITING